Molecular targeting of angiogenesis
- 4 March 2004
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1654 (1) , 39-49
- https://doi.org/10.1016/j.bbcan.2003.08.001
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Tumor‐targeting properties of antibody–vascular endothelial growth factor fusion proteinsInternational Journal of Cancer, 2002
- Pre-Targeted Locoregional Radioimmunotherapy with 90Y-biotin in Glioma Patients: Phase I Study and Preliminary Therapeutic ResultsCancer Biotherapy & Radiopharmaceuticals, 2001
- Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglinEuropean Journal Of Cancer, 2000
- Angiogenesis: How a Tumor Adapts to HypoxiaBiochemical and Biophysical Research Communications, 1999
- Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant AntibodyThe American Journal of Pathology, 1999
- Leydig cells secrete factors which increase vascular permeability and endothelial cell proliferationInternational Journal of Andrology, 1996
- Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissuesInternational Journal of Cancer, 1992
- The macroscopic and microscopic pharmacology of monoclonal antibodiesInternational Journal of Immunopharmacology, 1992
- Angiogenesis and NeoplasiaNew England Journal of Medicine, 1981
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971